The robotic probe attempted to collect a sample scattered from a crater made on the surface of the space rock Ryugu in April.
We all have things we’d rather forget. But for over four million people in the US who suffer from post-traumatic stress disorder (PTSD), that need becomes very real.
Erasing memories has always been the stuff of science fiction and wishful thinking. After all, what happened, happened—your experiences are solidified in your head as part of your past, perhaps even molding your personality.
But does it have to be this way?
The Longevity industry will dwarf all other industries in both size and market capitalization and will require unprecedented sophistication in its approach for assessment and forecasting from the start to neutralize challenges and manifest opportunities
The Longevity Industry is not just about biotechnology and biomedicine. Rather, it consists of several distinct segments: Geroscience, Biomedicine, AgeTech and Finance. Despite this seemingly clear market segmentation, many of these sectors intersect with various domains of science and technology, such as advanced biomedicine, preventive medicine, digital health, AI, financial systems, pension systems and government national strategies.
One of the biggest challenges in assessing the Longevity industry is the extreme broadness of the sector. Hundreds of sectors, industries and domains of science and technology must be analyzed in order to obtain a concrete and comprehensive understanding of the dynamics, trends and direction of the industry. This situation is entirely unique to the Longevity industry. Due to this extreme level of complexity, realistic assessment and forecasting is extremely challenging, and the methods currently being applied for assessment of the biotech and biomedical industries are completely inadequate.
The past decade of Alzheimer’s disease research has been fraught with disappointment.
Years of focus on one hallmark of the disease ultimately resulted in no progress toward treatment or prevention.
But next week, when top scientists gather in Los Angeles at the Alzheimer’s Association International Conference, an annual meeting, many will present research on a different target: inflammation.
A simple cold virus could wipe out tumors in a form of bladder cancer, a small new study suggests.
Though the idea of using viruses to fight cancer isn’t new, this is the first time a cold virus effectively treated an early-stage form of bladder cancer. In one patient, it eliminated a cancerous tumor, the group reported July 4 in the journal Clinical Cancer Research.
A group of researchers conducted an early-stage clinical trial in which they infected 15 bladder cancer patients with coxsackievirus A21, which is one of the viruses that cause the common cold. Coxsackievirus is not a genetically modified virus; it’s “something that occurs in nature,” said senior author Hardev Pandha, a professor of medical oncology at the University of Surrey in England. [Exercise May Reduce the Risk of These 13 Cancers].
Watch highlights from the first virtual debate among U.S. Transhumanist Party / Transhuman Party (USTP) candidates for President of the United States, which took place on Saturday, July 6, 2019, at 3 p.m. U.S. Pacific Time. Candidates Rachel Haywire, Johannon Ben Zion, and Charles Holsopple discussed how their platforms reflect the Core Ideals of the USTP and also answered selected questions from the public.
This highlights reel was created by Tom Ross, the USTP Director of Media Production. Watch the full 3-hour debate here: https://www.youtube.com/watch?v=LeKsUFTzPv0
Learn about the USTP candidates here: https://transhumanist-party.org/candidate-profiles/
View individual candidate profiles:
Is comprehensive damage repair feasible? A debate at Undoing Aging 2019 between Vadim Gladyshev, Harvard Medical School and Aubrey de Grey, SENS Research Foundation.
PLEASE LIKE & SUBSCRIBE FOR MORE FROM MY NMN CHANNEL
Vadim N. Gladyshev is a professor at Harvard Medical School, Brigham and Women’s Hospital and an expert and pioneer in antioxidant/redox biology. He is known for his characterization of the human selenoproteinencoded by 25 genes. He has conducted studies on whether organisms can acquire cellular damage from their food;the role selenium plays as a micro-nutrient with significant health benefits;In 2013 he won the NIH Pioneer Award.
Aubrey David Nicholas Jasper de Grey is an English author and biomedical gerontologist. He is the Chief Science Officer of the SENS Research Foundation and VP of New Technology Discovery at AgeX Therapeutics, Inc.
TrickBot malware may have stolen as many as 250 million email accounts, including some belonging to governments in the US, UK and Canada. The malware isn’t new. In fact, it’s been circulating since 2016. But according to cybersecurity firm Deep Instinct, it has started harvesting email credentials and contacts. The researchers are calling this new approach TrickBooster, and they say it first hijacks accounts to send malicious spam emails and then deletes the sent messages from both the outbox and trash folders.
A 22-year-old woman from the Netherlands who suffers from a chronic bone disorder — which has increased the thickness of her skull from 1.5cm to 5cm, causing reduced eyesight and severe headaches — has had the top section of her skull removed and replaced with a 3D printed implant.
The operation was performed by a team of neurosurgeons at the University Medical Centre Utrecht and the university claims this is this first instance of a successful 3D printed cranium that has not been rejected by the patient.